APA
Willett C. G., Boucher Y., Duda D. G., di Tomaso E., Munn L. L., Tong R. T., Kozin S. V., Petit L., Jain R. K., Chung D. C., Sahani D. V., Kalva S. P., Cohen K. S., Scadden D. T., Fischman A. J., Clark J. W., Ryan D. P., Zhu A. X., Blaszkowsky L. S., Shellito P. C., Mino-Kenudson M. & Lauwers G. Y. (20051209). Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Willett Christopher G, Boucher Yves, Duda Dan G, di Tomaso Emmanuelle, Munn Lance L, Tong Ricky T, Kozin Sergey V, Petit Lucine, Jain Rakesh K, Chung Daniel C, Sahani Dushyant V, Kalva Sanjeeva P, Cohen Kenneth S, Scadden David T, Fischman Alan J, Clark Jeffrey W, Ryan David P, Zhu Andrew X, Blaszkowsky Lawrence S, Shellito Paul C, Mino-Kenudson Mari and Lauwers Gregory Y. 20051209. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Willett C. G., Boucher Y., Duda D. G., di Tomaso E., Munn L. L., Tong R. T., Kozin S. V., Petit L., Jain R. K., Chung D. C., Sahani D. V., Kalva S. P., Cohen K. S., Scadden D. T., Fischman A. J., Clark J. W., Ryan D. P., Zhu A. X., Blaszkowsky L. S., Shellito P. C., Mino-Kenudson M. and Lauwers G. Y. (20051209). Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Willett Christopher G, Boucher Yves, Duda Dan G, di Tomaso Emmanuelle, Munn Lance L, Tong Ricky T, Kozin Sergey V, Petit Lucine, Jain Rakesh K, Chung Daniel C, Sahani Dushyant V, Kalva Sanjeeva P, Cohen Kenneth S, Scadden David T, Fischman Alan J, Clark Jeffrey W, Ryan David P, Zhu Andrew X, Blaszkowsky Lawrence S, Shellito Paul C, Mino-Kenudson Mari and Lauwers Gregory Y. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20051209.